Price Alert

Thorne HealthTech Inc. (THRN)

NASDAQ: THRN · Real-Time Price · USD

10.19

-0.01 (-0.10%)

At close: Oct 13, 2023, 10:00 PM

Thorne HealthTech Statistics

Share Statistics

Thorne HealthTech has 54.04M shares outstanding. The number of shares has increased by 0% in one year.

Shares Outstanding	54.04M
Shares Change (YoY)	0%
Shares Change (QoQ)	0%
Owned by Institutions (%)	n/a
Shares Floating	15.73M
Failed to Deliver (FTD) Shares	28,555
FTD / Avg. Volume	11.66%

Short Selling Information

The latest short interest is 267.44K, so 0% of the outstanding shares have been sold short.

Short Interest	267.44K
Short % of Shares Out	n/a
Short % of Float	2.19%
Short Ratio (days to cover)	2.64

Valuation Ratios

The PE ratio is 12.22 and the forward PE ratio is null. Thorne HealthTech's PEG ratio is 0.24.

PE Ratio	12.22
Forward PE	n/a
PS Ratio	0.84
Forward PS	n/a
PB Ratio	1.32
P/FCF Ratio	-15.15
PEG Ratio	0.24

Financial Ratio History

Enterprise Valuation

Thorne HealthTech has an Enterprise Value (EV) of 202.52M.

EV / Sales	0.89
EV / EBITDA	19.65
EV / EBIT	38.78
EV / FCF	-16.02

Financial Position

The company has a current ratio of 2.95, with a Debt / Equity ratio of 0.32.

Current Ratio	2.95
Quick Ratio	1.47
Debt / Equity	0.32
Debt / EBITDA	4.56
Debt / FCF	-3.72
Interest Coverage	208.19

Financial Efficiency

Return on Equity is 10.81% and Return on Invested Capital is 5.45%.

Return on Equity	10.81%
Return on Assets	6.82%
Return on Invested Capital	5.45%
Revenue Per Employee	$420.46K
Profits Per Employee	$28.81K
Employee Count	544
Asset Turnover	1
Inventory Turnover	1.94

Taxes

Income Tax	-7.31M
Effective Tax Rate	-93.75%

Stock Price Statistics

The stock price has increased by 0% in the last 52 weeks. The beta is 0.82, so Thorne HealthTech's price volatility has been higher than the market average.

Beta	0.82
52-Week Price Change	n/a
50-Day Moving Average	9.24
200-Day Moving Average	5.78
Relative Strength Index (RSI)	72.14
Average Volume (20 Days)	244,810

Income Statement

In the last 12 months, Thorne HealthTech had revenue of 228.73M and earned 15.67M in profits. Earnings per share was 0.3.

Revenue	228.73M
Gross Profit	114.93M
Operating Income	5.48M
Net Income	15.67M
EBITDA	10.31M
EBIT	7.82M
Earnings Per Share (EPS)	0.3

Full Income Statement

Balance Sheet

The company has 36.02M in cash and 47.03M in debt, giving a net cash position of -11.01M.

Cash & Cash Equivalents	36.02M
Total Debt	47.03M
Net Cash	-11.01M
Retained Earnings	-116.48M
Total Assets	282.53M
Working Capital	79.22M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 5.22M and capital expenditures -17.86M, giving a free cash flow of -12.64M.

Operating Cash Flow	5.22M
Capital Expenditures	-17.86M
Free Cash Flow	-12.64M
FCF Per Share	-0.24

Full Cash Flow Statement

Margins

Gross margin is 50.25%, with operating and profit margins of 2.4% and 6.85%.

Gross Margin	50.25%
Operating Margin	2.4%
Pretax Margin	3.41%
Profit Margin	6.85%
EBITDA Margin	4.51%
EBIT Margin	2.4%
FCF Margin	-5.53%

Dividends & Yields

THRN does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Payout Ratio	n/a
Earnings Yield	8.18%
FCF Yield	-6.6%

Dividend Details

Analyst Forecast

Currently there are no analyst rating for THRN.

Price Target	n/a
Price Target Difference	n/a
Analyst Consensus	n/a
Analyst Count	n/a

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	4.29
Graham Upside	-57.9%

Scores

Altman Z-Score	3.44
Piotroski F-Score	4